How Will the NGS-Based RNA-Sequencing Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the ngs-based rna-sequencing market?
In the recent past, there has been a substantial growth in the market size of NGS-based RNA-sequencing. The market, which was valued at $3.41 billion in 2024, is predicted to surge to a value of $4.23 billion in 2025, representing a compound annual growth rate (CAGR) of 24.2%. Various factors have contributed to the growth witnessed in the historic period, including initiatives in genomic research, a decrease in sequencing costs, drug discovery and development, the proliferation of personalized medicine, and the increased acceptance of NGS.
What will be the ngs-based rna-sequencing market size in the future?
Over the next few years, the market size for NGS-based RNA-sequencing is anticipated to experience a significant upsurge. It is projected to reach $10.4 billion in 2029, with an annual compound growth rate (CAGR) of 25.2%. This growth throughout the forecast period is mainly due to clinical diagnostics, global collaborations, ethical and regulatory frameworks, and research in agriculture and environment, along with green genomics. Single-cell RNA-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, and sustainable agriculture are the main trends expected during this forecast period.
Get your ngs-based rna-sequencing market report here!
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
What main drivers are fueling expansion in the ngs-based rna-sequencing market?
The NGS-based RNA sequencing market is expanding on the back of advancements in precision medicine. By providing doctors with the capacity to create patient-specific treatment plans grounded in genetic understanding of diseases, precision medicine is transforming healthcare, particularly concerning serious illnesses like cancer. The role of NGS-based RNA sequencing is crucial here as it identifies the fundamental cause of the disease, thus paving the way for suitably customized precision medicine. As corroborated by a report from the Personalized Medicine Coalition (PMC), a nonprofit organization based in the U.S., personalized medicines made up 35% of the newly approved NMEs in 2021. Further enhancing their presence with 12 new approvals in 2022, they continually represented at least 25% of new drug endorsements over the last eight years. This is a noteworthy leap from less than 10% a decade earlier. Correspondingly, as the popularity of precision medicines surges, so will the need for NGS-based RNA sequencing.
What key areas define the segmentation of the global ngs-based rna-sequencing market?
The ngs-based rna-sequencing market covered in this report is segmented –
1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management
2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing
3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics
4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users
Subsegments:
1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents
2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables
3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services
4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp
Who are the dominant players expanding their reach in the ngs-based rna-sequencing market?
Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.
How are evolving market trends shaping ngs-based rna-sequencing Strategies?
The trend of Strategic Partnership holds significant sway in the NGS-based RNA sequencing market. To penetrate into new markets and employ each other’s resources to their advantage, companies are forming alliances with NGS-based RNA sequencing firms. For instance, in May 2022, The Biomedical Advanced Research and Development Authority (BARDA), which comes under the aegis of the U.S. Department of Health and Human Services, forged synergies with numerous industry and academic associates. The prime goal of this collaboration is to strengthen the ability to quickly tackle public health crises and formulate a unique diagnostic method that accommodates all known and emerging respiratory RNA viruses with a single test.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7416
Which regions are emerging as leaders in the ngs-based rna-sequencing market?
North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Antisense & RNAi Therapeutics Global Market Report 2024
Biosimilar Hormones Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report
Microbiology Diagnostic Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
